AI English summary of an SEC filing — figures as filed
Labcorp said Glenn Eisenberg notified it on November 15, 2024 of his intention to retire, effective April 30, 2025. The company said Julia Wang was appointed Executive Vice President and Chief Financial Officer, and Mr. Eisenberg will step down from his CFO role on December 2, 2024.
Key points
AI summaryLabcorp said Glenn Eisenberg notified it on November 15, 2024 of his intention to retire, effective April 30, 2025. The company said Julia Wang was appointed Executive Vice President and Chief Financial Officer, and Mr. Eisenberg will step down from his CFO role on December 2, 2024.
Labcorp said Eisenberg will serve as Special Advisor to the Chief Executive Officer from December 2, 2024 through his retirement date. The company said he will help with the transition of his current role and support strategic initiatives underway.
Labcorp said Wang's annual base salary will be $725,000, and her annual bonus target for 2025 will be 100% of her base salary. The company said it will pay Wang a sign-on bonus of $400,000, with $200,000 payable 30 days after the Transition Date and $200,000 payable on the 1-year anniversary of the Transition Date.
Labcorp said that on the Transition Date, Wang will receive performance share awards based on $1,920,000, time-based stock options with a grant-date fair value of $640,000, and restricted stock units based on $640,000. The company said these Sign-On Equity Grants will vest in equal installments consistent with the 2024 annual equity awards granted to its executive officers.
Summary
AI-writtenAnalysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
CFO transition: Eisenberg retires, Julia Wang appointed
Labcorp said Glenn Eisenberg notified it on November 15, 2024 of his intention to retire, effective April 30, 2025. The company said Julia Wang was appointed Executive Vice President and Chief Financial Officer, and Mr. Eisenberg will step down from his CFO role on December 2, 2024.
Source · Based on the filing body and exhibits
Eisenberg's role as Special Advisor
Labcorp said Eisenberg will serve as Special Advisor to the Chief Executive Officer from December 2, 2024 through his retirement date. The company said he will help with the transition of his current role and support strategic initiatives underway.
Source · Based on the filing body and exhibits
Julia Wang's compensation terms
Labcorp said Wang's annual base salary will be $725,000, and her annual bonus target for 2025 will be 100% of her base salary. The company said it will pay Wang a sign-on bonus of $400,000, with $200,000 payable 30 days after the Transition Date and $200,000 payable on the 1-year anniversary of the Transition Date.
Source · Based on the filing body and exhibits
Wang's new-hire equity awards
Labcorp said that on the Transition Date, Wang will receive performance share awards based on $1,920,000, time-based stock options with a grant-date fair value of $640,000, and restricted stock units based on $640,000. The company said these Sign-On Equity Grants will vest in equal installments consistent with the 2024 annual equity awards granted to its executive officers.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…